Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression. [electronic resource]
Producer: 20180529Description: E6137-E6146 p. digitalISSN:- 1091-6490
- Animals
- Azacitidine -- analogs & derivatives
- Basic Helix-Loop-Helix Transcription Factors -- genetics
- Cell Proliferation -- genetics
- Chemotherapy, Adjuvant
- Decitabine
- Female
- Genetic Therapy -- methods
- Hypoxia-Inducible Factor 1, alpha Subunit -- genetics
- Mice
- Mice, Nude
- Neuroblastoma -- pathology
- Tretinoin -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.